文献速递结核与非结核分枝杆菌

左氧氟沙星治疗耐多药结核的药代动力学/药效学、剂量、敏感性折点与人工智能

Levofloxacin Pharmacokinetics/Pharmacodynamics, Dosing, Susceptibility Breakpoints, and Artificial Intelligence in the Treatment of Multidrug-resistant Tuberculosis.
PubMed 文献 · Clin Infect Dis · 2018-01-01

本研究利用结核空心纤维系统模型确定左氧氟沙星的最大杀菌和抑制耐药所需的AUC0-24/MIC靶值,并通过蒙特卡洛实验、人工智能算法和概率回归分析,在耐多药结核患者中评估最佳剂量。结果显示最大杀菌靶值为146,抑制耐药靶值为360,最低有效剂量为1500 mg/日,人工智能识别AUC0-24/MIC 160预测微生物学治愈,概率回归确定25 mg/kg与>90%有利反应相关。结论认为25 mg/kg或1500 mg/日足以替代高剂量莫西沙星。

要点

  • 左氧氟沙星最大杀菌AUC0-24/MIC为146,抑制耐药为360。
  • 蒙特卡洛实验确定最低有效剂量为1500 mg/日。
  • AI识别AUC0-24/MIC 160预测微生物学治愈。

核心结论

  • 左氧氟沙星25 mg/kg或1500 mg/日足以替代高剂量莫西沙星治疗耐多药结核。

研究设计与样本

  • 采用结核空心纤维系统模型确定药效靶值,并进行全基因组测序、蒙特卡洛实验、人工智能算法分析和概率回归。

主要发现

  • 空心纤维系统中最大杀菌AUC0-24/MIC为146,抑制耐药为360。
  • 耐药菌常见gyrA突变为Asp94Gly、Asp94Asn和Asp94Tyr。
  • 蒙特卡洛实验确定达到靶暴露的最低剂量为1500 mg/日。
  • AI算法识别AUC0-24/MIC 160预测微生物学治愈,其次为左氧氟沙星2小时峰浓度和体重。
  • 概率回归确定25 mg/kg与>90%有利反应相关。

关键数值与推荐

  • 最大杀菌靶值AUC0-24/MIC=146,抑制耐药靶值=360。
  • 蒙特卡洛实验最低有效剂量1500 mg/日。
  • AI预测微生物学治愈的AUC0-24/MIC=160。
  • 概率回归确定25 mg/kg与>90%有利反应相关。

临床怎么用

  • 耐多药结核治疗中左氧氟沙星可采用25 mg/kg或1500 mg/日剂量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Levofloxacin is used for the treatment of multidrug-resistant tuberculosis; however the optimal dose is unknown. METHODS: We used the hollow fiber system model of tuberculosis (HFS-TB) to identify 0-24 hour area under the concentration-time curve (AUC0-24) to minimum inhibitory concentration (MIC) ratios associated with maximal microbial kill and suppression of acquired drug resistance (ADR) of Mycobacterium tuberculosis (Mtb). Levofloxacin-resistant isolates underwent whole-genome sequencing. Ten thousands patient Monte Carlo experiments (MCEs) were used to identify doses best able to achieve the HFS-TB-derived target exposures in cavitary tuberculosis and tuberculous meningitis. Next, we used an ensemble of artificial intelligence (AI) algorithms to identify the most important predictors of sputum conversion, ADR, and death in Tanzanian patients with pulmonary multidrug-resistant tuberculosis treated with a levofloxacin-containing regimen. We also performed probit regression to identify optimal levofloxacin doses in Vietnamese tuberculous meningitis patients. RESULTS: In the HFS-TB, the AUC0-24/MIC associated with maximal Mtb kill was 146, while that associated with suppression of resistance was 360. The most common gyrA mutations in resistant Mtb were Asp94Gly, Asp94Asn, and Asp94Tyr. The minimum dose to achieve target exposures in MCEs was 1500 mg/day. AI algorithms identified an AUC0-24/MIC of 160 as predictive of microbiologic cure, followed by levofloxacin 2-hour peak concentration and body weight. Probit regression identified an optimal dose of 25 mg/kg as associated with >90% favorable response in adults with pulmonary tuberculosis. CONCLUSIONS: The levofloxacin dose of 25 mg/kg or 1500 mg/day was adequate for replacement of high-dose moxifloxacin in treatment of multidrug-resistant tuberculosis.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Deshpande D, Pasipanodya JG, Mpagama SG, et al. Levofloxacin Pharmacokinetics/Pharmacodynamics, Dosing, Susceptibility Breakpoints, and Artificial Intelligence in the Treatment of Multidrug-resistant Tuberculosis. Clin Infect Dis. 2018. PMID: 30496461. doi:10.1093/cid/ciy611

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。